The HELIOS trial protocol: A Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia

Michael Hallek, Neil E. Kay, Anders Osterborg, Asher A. Chanan-Khan, Michelle Mahler, Mariya Salman, Ying Wan, Steven Sun, Sen Hong Zhuang, Angela Howes

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'The HELIOS trial protocol: A Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences